Zhaoyan New Drug shareholders adjust their reduction plan, with the total reduction ratio decreasing to 3%

Zhongfang Network Data: Beijing Zhaoyan New Drug Research Center Co., Ltd. (Zhaoyan New Drug, 603127) released a correction announcement on March 18, making significant adjustments to its shareholders’ reduction plan. According to the corrected content, the total reduction ratio of shareholders Gu Xiaolei and his concerted action person Gu Meifang has been adjusted from the original plan of not exceeding 4.1026% of the company’s total share capital to 3.00%. At the same time, the method of reduction has also changed from a single centralized bidding transaction to a combination of centralized bidding and block trading.

Specifically, Gu Xiaolei plans to reduce his holdings by no more than 15,061,800 shares, accounting for 2.01% of the company’s total share capital. Among them, he will reduce no more than 5,020,600 shares through centralized bidding and no more than 10,041,200 shares through block trading. Gu Meifang plans to reduce her holdings by no more than 7,418,400 shares, accounting for 0.99% of the company’s total share capital. Among them, she will reduce no more than 2,472,800 shares through centralized bidding and no more than 4,945,600 shares through block trading. The shares to be reduced this time are all from the company’s pre-IPO restricted shares and capital reserves converted shares.

The reduction period is within 3 months starting from March 20, 2026, until June 19, 2026. The reduction price will be determined based on market prices. The announcement mentioned that both shareholders’ reasons for reducing their holdings are due to personal funding needs. The company stated that if any rights issues such as stock dividends or capital increases occur during the implementation of the reduction plan, the number of shares to be reduced will be adjusted accordingly. This adjustment to the reduction plan lowers the proportion of shares that shareholders can directly sell in the secondary market through centralized bidding in the short term, which may help reduce the direct impact on the secondary market stock price.

Massive information, precise interpretation, all available on the Sina Finance APP.